-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Outlook Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2015 to Q1 2025.
- Outlook Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2025 was $2.8K, unchanged year-over-year.
- Outlook Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2024 was $2.8K, unchanged from 2023.
- Outlook Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $2.8K, unchanged from 2022.
- Outlook Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $2.8K, a 40% increase from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)